BAILLIE GIFFORD & CO 13D and 13G filings for Ionis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-02 09:38 am Sale |
2020-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BAILLIE GIFFORD & CO | 4,920,843 3.520% |
-3,869,182 (-44.02%) |
Filing |